Cross Country Healthcare (CCRN - Free Report) closed at $28.67 in the latest trading session, marking a +0.03% move from the prior day. This change lagged the S&P 500's 2.28% gain on the day. Elsewhere, the Dow gained 2.13%, while the tech-heavy Nasdaq added 5.02%.
Coming into today, shares of the provider of health care staffing and workforce management services had lost 9.73% in the past month. In that same time, the Business Services sector lost 3.62%, while the S&P 500 lost 4.61%.
Wall Street will be looking for positivity from Cross Country Healthcare as it approaches its next earnings report date. The company is expected to report EPS of $0.90, down 35.71% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $594.17 million, down 7.26% from the year-ago period.
Investors might also notice recent changes to analyst estimates for Cross Country Healthcare. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Cross Country Healthcare is currently a Zacks Rank #2 (Buy).
Digging into valuation, Cross Country Healthcare currently has a Forward P/E ratio of 8.99. Its industry sports an average Forward P/E of 11.45, so we one might conclude that Cross Country Healthcare is trading at a discount comparatively.
Meanwhile, CCRN's PEG ratio is currently 1.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Staffing Firms stocks are, on average, holding a PEG ratio of 1.38 based on yesterday's closing prices.
The Staffing Firms industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 72, which puts it in the top 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Cross Country Healthcare (CCRN - Free Report) closed at $28.67 in the latest trading session, marking a +0.03% move from the prior day. This change lagged the S&P 500's 2.28% gain on the day. Elsewhere, the Dow gained 2.13%, while the tech-heavy Nasdaq added 5.02%.
Coming into today, shares of the provider of health care staffing and workforce management services had lost 9.73% in the past month. In that same time, the Business Services sector lost 3.62%, while the S&P 500 lost 4.61%.
Wall Street will be looking for positivity from Cross Country Healthcare as it approaches its next earnings report date. The company is expected to report EPS of $0.90, down 35.71% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $594.17 million, down 7.26% from the year-ago period.
Investors might also notice recent changes to analyst estimates for Cross Country Healthcare. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Cross Country Healthcare is currently a Zacks Rank #2 (Buy).
Digging into valuation, Cross Country Healthcare currently has a Forward P/E ratio of 8.99. Its industry sports an average Forward P/E of 11.45, so we one might conclude that Cross Country Healthcare is trading at a discount comparatively.
Meanwhile, CCRN's PEG ratio is currently 1.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Staffing Firms stocks are, on average, holding a PEG ratio of 1.38 based on yesterday's closing prices.
The Staffing Firms industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 72, which puts it in the top 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CCRN - FREE